Search Results - "Urrunaga, D."
-
1
Ki67 as an important predictor for oncotype Dx recurrence score risk groups in early breast cancer
Published in Annals of oncology (01-10-2018)Get full text
Journal Article -
2
Oncotype Dx results in patients ≤40 years: Does age matter? New insights
Published in Annals of oncology (01-10-2018)Get full text
Journal Article -
3
SARC-F and SARC-CalF Scores as Mortality Risk Factors in Older Men with Cancer: A Longitudinal Study from Peru
Published in The Journal of nutrition, health & aging (01-09-2022)“…Objectives We aimed to evaluate the role of SARC-F and SARC-CalF scores as risk factors for mortality in adults over 60 years of age with cancer of the Centro…”
Get full text
Journal Article -
4
Frailty and Vulnerability as Predictors of Chemotherapy Toxicity in Older Adults: A Longitudinal Study in Peru
Published in The Journal of nutrition, health & aging (01-09-2020)“…Background Multiple markers are used to assess frailty and vulnerability, conditions associated with the development of chemotherapy toxicity (CTT). However,…”
Get full text
Journal Article -
5
Frailty and Vulnerability as Predictors of Chemotherapy Toxicity in Older Adults: A Longitudinal Study in Peru
Published in The Journal of nutrition, health & aging (2020)“…Multiple markers are used to assess frailty and vulnerability, conditions associated with the development of chemotherapy toxicity (CTT). However, there is…”
Get full text
Journal Article -
6
Abstract P3-08-18: Clinicopathological characteristics associated with intermediate and high-risk ODx RS
Published in Cancer research (Chicago, Ill.) (15-02-2019)“…Background: The gene expression profiling assay OncotypeDx (ODx) prognosticates the risk of estrogen receptor positive (ER+) breast cancer (BC) recurrence and…”
Get full text
Journal Article -
7
Abstract P3-08-16: Age's importance in early breast cancer: Oncotype Dx results in patients ≤40 years
Published in Cancer research (Chicago, Ill.) (15-02-2019)“…Background The 21-gene recurrence score (RS) predicts the benefit of adjuvant chemotherapy (CT) in ER-positive HER2-negative breast cancer (BC) and has been…”
Get full text
Journal Article -
8
214PKi67 as an important predictor for oncotype Dx recurrence score risk groups in early breast cancer
Published in Annals of oncology (01-10-2018)Get full text
Journal Article -
9
Abstract P3-08-17: Evaluation of Oncotype DX testing and subsequent treatment choices in the Latin American setting
Published in Cancer research (Chicago, Ill.) (15-02-2019)“…Background: The gene expression profiling assay OncotypeDx (ODx) prognosticates the risk of estrogen receptor positive (ER+) breast cancer (BC) recurrence and…”
Get full text
Journal Article -
10
211POncotype Dx results in patients ≤40 years: Does age matter? New insights
Published in Annals of oncology (01-10-2018)Get full text
Journal Article -
11
Letter to the Editor: COVID-19 Mortality in Peruvian Older Adults: A Chronicle of a Health Crisis Foretold?
Published in The Journal of frailty & aging (2021)Get full text
Journal Article -
12
COVID-19 Mortality in Peruvian Older Adults: A Chronicle of a Health Crisis Foretold?
Published in The Journal of frailty & aging (01-02-2021)“…Physiological changes associated with aging, a decrease in immune system response, the presence of disability, chronic diseases and polypharmacy are…”
Get full text
Journal Article -
13
-
14
-
15